Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Neurogastroenterology and Motility
|
February 18, 2010
Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat
B Yüce, M Kemmer, G Qian, et al.
Neurogastroenterology and Motility
|
March 19, 2011
Effect of GABA-ergic mechanisms on synaptosomal NO synthesis and the nitrergic component of NANC relaxation in rat ileum
M Kurjak, J Fichna, J Harbarth, et al.
BMC Gastroenterology
|
August 15, 2002
Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment
M Storr, P Born, E Frimberger, et al.
Journal of Pineal Research
|
August 3, 2002
Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro
M Storr, P Koppitz, A Sibaev, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
July 16, 2017
Highly selective CB<sub>2</sub> receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice
M Salaga, H Zatorski, M Zielińska, et al.
Neurogastroenterology and Motility
|
August 31, 2007
Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex
B Yuece, A Sibaev, U C Broedl, et al.
Neurogastroenterology and Motility
|
August 1, 2015
The GPR55 antagonist CID16020046 protects against intestinal inflammation
A Stančić, K Jandl, C Hasenöhrl, et al.
Zeitschrift Fur Gastroenterologie
|
September 15, 2009
[Performance and interpretation of esophageal manometry: recommendations of the German Societies for Neurogastroenterology and Motility (DGNM), for Digestive and Metabolic Diseases (DGVS) and for General and Visceral Surgery (DGAV)]
J Keller, I van der Voort, C Pehl, et al.
Alimentary Pharmacology & Therapeutics
|
December 5, 2008
The role of fatty acid hydrolase gene variants in inflammatory bowel disease
M Storr, D Emmerdinger, J Diegelmann, et al.
Computer Methods and Programs in Biomedicine
|
September 7, 2013
Kinetic modelling of haemodialysis removal of myoglobin in rhabdomyolysis patients
R Keir, N D Evans, C A Hutchison, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Neurogastroenterology and Motility
|
February 18, 2010
Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat
B Yüce, M Kemmer, G Qian, et al.
Neurogastroenterology and Motility
|
March 19, 2011
Effect of GABA-ergic mechanisms on synaptosomal NO synthesis and the nitrergic component of NANC relaxation in rat ileum
M Kurjak, J Fichna, J Harbarth, et al.
BMC Gastroenterology
|
August 15, 2002
Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment
M Storr, P Born, E Frimberger, et al.
Journal of Pineal Research
|
August 3, 2002
Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro
M Storr, P Koppitz, A Sibaev, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
July 16, 2017
Highly selective CB<sub>2</sub> receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice
M Salaga, H Zatorski, M Zielińska, et al.
Neurogastroenterology and Motility
|
August 31, 2007
Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex
B Yuece, A Sibaev, U C Broedl, et al.
Neurogastroenterology and Motility
|
August 1, 2015
The GPR55 antagonist CID16020046 protects against intestinal inflammation
A Stančić, K Jandl, C Hasenöhrl, et al.
Zeitschrift Fur Gastroenterologie
|
September 15, 2009
[Performance and interpretation of esophageal manometry: recommendations of the German Societies for Neurogastroenterology and Motility (DGNM), for Digestive and Metabolic Diseases (DGVS) and for General and Visceral Surgery (DGAV)]
J Keller, I van der Voort, C Pehl, et al.
Alimentary Pharmacology & Therapeutics
|
December 5, 2008
The role of fatty acid hydrolase gene variants in inflammatory bowel disease
M Storr, D Emmerdinger, J Diegelmann, et al.
Computer Methods and Programs in Biomedicine
|
September 7, 2013
Kinetic modelling of haemodialysis removal of myoglobin in rhabdomyolysis patients
R Keir, N D Evans, C A Hutchison, et al.
Page
of 12